Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01204749
Recruitment Status : Completed
First Posted : September 17, 2010
Last Update Posted : December 15, 2016
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2013
Actual Study Completion Date : December 2016
Certification/Extension First Submitted : June 2, 2014
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):